2,723 hedge funds and large institutions have $145B invested in Pfizer in 2021 Q2 according to their latest regulatory filings, with 187 funds opening new positions, 1,279 increasing their positions, 997 reducing their positions, and 97 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

2% more funds holding

Funds holding: 2,6662,723 (+57)

0.55% more ownership

Funds ownership: 65.76%66.31% (+0.55%)

10% less call options, than puts

Call options by funds: $2.23B | Put options by funds: $2.47B

Holders
2,723
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
70
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.23B
Puts
$2.47B
Net Calls
Net Calls Change

Top Buyers

1 +$396M
2 +$359M
3 +$207M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$179M
5
N
Natixis
France
+$173M

Top Sellers

1 -$316M
2 -$292M
3 -$182M
4
Bank of America
Bank of America
North Carolina
-$154M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$144M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$17.9B
2
$15.9B
3
$10.9B
4
$9.47B
5
$9.41B
6
$3.76B
7
$2.52B
8
$2.5B
9
$2.31B
10
$2.3B
11
$2.21B
12
$2.14B
13
$1.88B
14
$1.56B
15
$1.46B
16
$1.43B
17
$1.4B
18
$1.34B
19
$1.31B
20
$1.24B
21
$1.17B
22
$1.06B
23
$993M
24
$961M
25
$951M